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CDC25BSelenoprotein W (SelW) contains a highly reactive selenocysteine (Sec; U) in the CXXU motif corresponding
to the CXXC motif in thioredoxin (Trx) and thus it appears to be involved in regulating the cellular redox
state. Recent reports on the interaction between SelW and 14-3-3 suggest that SelW may be redox depen-
dently involved in the cell cycle. However, the precise function of SelW has not yet been elucidated. Here,
we show that SelW is involved in the G2–M transition, especially in the recovery from G2 arrest after
deoxyribonucleic acid (DNA) damage. Knockdown of SelW signiﬁcantly accumulated phosphorylated
cyclin‐dependent kinase (Cdk1), which eventually led to a delay in recovery from G2 arrest. We also found
that inactive Cdk1 is caused by the sustained inactivation of CDC25B, which removes the inhibitory phos-
phate from Cdk1. Our observation from this study reveals that SelW activated CDC25B by promoting the dis-
sociation of 14-3-3 from CDC25B through the reduction of the intramolecular disulﬁde bond during recovery.
We suggest that SelW plays an important role in the recovery from G2 arrest by determining the dissociation
of 14-3-3 from CDC25B in a redox-dependent manner.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Selenoproteins contain selenium in the form of Sec, and their abnor-
mal expression is associatedwith various diseases, such as cancer [1]. In
humans, 25 selenoproteins have been identiﬁed, some selenoproteins
have been shown to display antioxidant activity [2,3]. Although their
tissue distribution indicates that each selenoprotein possesses a novel
function, not all selenoproteins have been fully characterized.
SelW is a low molecular weight (10 kDa) selenoprotein, and it
contains a single Sec at the 13th amino acid position. SelW is expressed
in several tissues and is especially abundant in the skeletal muscle and
brain [4] and is known to be localized in the cytosol [5]. Because SelW
contains a conserved CXXU motif, which corresponds to the CXXC
motif in Trx, and a glutathione (GSH) binding site at Cys 37, it may be
involved in cellular redox regulation. Previously, we suggested that
SelW displays GSH-dependent antioxidant activity in vivo, and Sec
was shown to be necessary for this activity [6]. We also reported that
the sensitivity of mouse embryonic neuronal cells against oxidative
stress was increased by SelW knockdown and that the expression
pattern of SelW differed from that of Trx during brain development
[7]. It has been suggested that SelW interacts with 14-3-3 proteins in-DA, 2’, 7’–dichloroﬂuorescein
odoacetamide; IR, irradiation;
omolog; ROS, reactive oxygen
SECIS, selenocysteine insertion
rights reserved.NIH3T3 cells, which are involved in various cellular processes, including
the cell cycle [8–10]. In addition, SelW may also modulate cell cycle
entry [11]. Although the possibility of SelW involvement in cell cycle
regulation was proposed, the precise function of SelW in the cell cycle
has not been established. In this study, we found that knockdown of
SelW delayed the G2–M transition in the cell cycle and caused signiﬁ-
cant retardation of recovery from G2 arrest, indicating that SelW may
be involved in the G2–M transition.
The G2–M transition of the cell cycle is tightly regulated by the Cdk1/
cyclin B1 complex. Cdk1 is kept in an inactive state by phosphorylation at
Thr 14 and Tyr 15, which is catalyzed by the Myt1 and Wee1 kinases,
respectively. At the G2–M transition, CDC25 phosphatases, which are
dual-speciﬁcity phosphatases, dephosphorylate both Thr 14 and Tyr 15,
resulting in the activation of the Cdk1/cyclin B1 complex and entrance
into mitosis [12,13]. Under genotoxic stress conditions, cell cycle pro-
gression is halted to allow time for DNA repair, thus, resulting in the
maintenance of genomic stability [14]. To prevent transmission of dam-
aged genetic material to daughter cells, entry into mitosis is controlled.
To achieve this, checkpoint kinases regulate the activity of Cdk1 [15].
However, when DNA repair is completed, cells inactivate the checkpoint
kinases and resume thenormal cell cycle,which is referred to as recovery
[16]. Although the mechanism of recovery from G2 arrest is not well
understood when compared to that of cell cycle arrest, the degradation
of Wee1 kinase mediated by polo-like kinase-1 and the activation of
the CDC25B isoform, not CDC25A or CDC25C, are essential for resump-
tion of the cell cycle from G2 arrest [17]. CDC25B contains an active Cys
in its catalytic site, which can form intramolecular disulﬁde bonds, and
is regulated in a redox-dependent manner [18]. However, the exact
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dent during the cell cycle is largely unknown. In addition, because the
activity of CDC25Bwas shown to be negatively regulated by interactions
with 14-3-3 proteins [19,20], which also interact with SelW, we sought
to determine whether the complex between SelW and 14-3-3 functions
in regulating the activity of CDC25B during cell cycle recovery. The disso-
ciation of 14-3-3 proteins and the reduction of intramolecular disulﬁde
bonds are required for the activation of CDC25B. A CDC25Cmutant inca-
pable of forming intramolecular disulﬁde bonds bound 14-3-3 to a lesser
degree than the wild type [21], suggesting that there is a relationship
between the formation of intramolecular disulﬁde bonds and the associ-
ation of 14-3-3 with CDC25B. Here, we show that SelW interacts with
CDC25B and their complex formation is increased after genotoxic stress;
downregulation of SelW leads to the accumulation of CDC25Bwith intra-
molecular disulﬁde bonds. In addition, CDC25B immunoprecipitation
analysis shows that SelW may regulate the dissociation of 14-3-3 from
CDC25B. Taken together, we suggest a redox mechanism of SelW by
which it reactivates CDC25B in the G2–M transition, especially during
the recovery process. In addition, we also found that SelW knockdown
cells were more sensitive to anticancer drugs. These ﬁndings suggest
that SelW might be a potential therapeutic target for cancer cells
overexpressing CDC25B and may increase the efﬁcacy of anticancer
agents.
2. Materials and methods
2.1. Cell culture, transfection and synchronization
NIH3T3 cells, mouse embryonic ﬁbroblast cells, were cultured in
DMEM supplemented with 10% FBS, and MCF7 cells, human breast
adenocarcinoma cells, were grown in RPMI supplemented with 10%
FBS at 37 °C in 5% CO2. For transient transfection, electroporation of
NIH3T3 or MCF7 cells was performed using a Neon transfection system
(Invitrogen, Carlsbad, CA, USA) according to themanufacturer's instruc-
tions. After transfection, NIH3T3 cells were subsequently incubated
with thymidine (2.5 mM) for 24 h to arrest cells at the G1/S transition.
The G2–M checkpoint was activated by a Cs 137 irradiator (8 Gy) or
etoposide (5 μM) for 1 h at 3.5 h after release from the thymidine
block. Cells were harvested at the indicated time points. For MCF7
cells, cells were subsequently incubated with thymidine (2.5 mM) for
16 h and then incubated with fresh medium for 9 h. The cells were
then incubated with thymidine for 16 h. 5 h after release, the cells
were treated with IR (8 Gy).
2.2. RNA interference and plasmids
siRNA corresponding to the human and mouse SelW gene was
designed and synthesized by Invitrogen (Stealth RNAi). Stealth RNAi
Negative Control Duplexes (Invitrogen) were used as a control in the
immunoprecipitation and immunoblot analysis. The sequences used
are listed in Table S1. A point mutation of SelW at Sec13 to Cys or Ser
was generated by site directedmutagenesis of the cDNA by polymerase
chain reaction (PCR) using the pcDNA 3.1+/SelW plasmid [6]. Mutant
cDNA was subcloned into the pcDNA3.1+/HIS C vector. HA-14-3-3β
was a gift from Prof. J. H. Hong (Korea University). CDC25B1-ﬂag was
a gift from Dr. K. Yamashita (Kanazawa University).
2.3. Antibodies and western blotting
Cells were lysed with lysis buffer containing 150 mM NaCl, 1%
NP-40, 0.1% SDS, 50 mM Tris (pH7.4), 1 mM EDTA, 1 mM PMSF,
5 μg/ml aprotinin, 5 μg/ml leupeptin and 3 mM DTT. Whole cell
lysates were separated with 6~12% SDS PAGE. Separated proteins
were transferred to a membrane, which was blocked subsequently
with 5% skimmilk for 30 min and then probed with antibodies specif-
ic for pan-14-3-3, CDC25B, WEE1, Cdk1, cyclin B1 (Santa Cruz, SantaCruz, CA, USA), phospho-CDC2 (Tyr15), phospho-Chk1 (Ser317),
Chk1, phospho-histone H3 (Ser10) (Cell Signaling, Danvers, MA,
USA), CDC25B (Epitomics, Burlingame, CA, USA ), His, HA (abm,
Richmond, BC, CANADA), ﬂag (Sigma, St. Louis, MO, USA), α-tubulin
(AB Frontier, Daejeon, Korea).
For detection of SelW, cell lysates were incubated with LDS sample
buffer and reducing reagent (Invitrogen) at 70 °C for 10 min. NuPAGE
12% Bis-Tris gel (Invitrogen) and SelW antibody were used. For detec-
tion of phospho-ATM and ATM, NuPAGE 3-8% Tris-Acetate gel
(Invitrogen) and phospho-ATM (Ser1981) (Novus, Littleton, CO, USA),
ATM (Genetex, Irvine, CA, USA) antibodies were used.
In the immunoblot forγ-H2AX, cells werewashedwith cold PBS and
resuspended with lysis buffer containing 20 mM Tris–HCl (pH 8.0),
150 mMNaCl, 1 mMEDTA (pH 8.0) and 0.5%NP-40 and then incubated
on ice for 15 min. After centrifugation at 6000×g for 5 min at 4 °C, the
supernatant was removed and the pellet was washed twice with lysis
buffer. The pellet was resuspended in 0.1 M HCl and incubated for
10 min at RT. Histone extracts were obtained by centrifugation at
6000×g for 5 min at 4 °C and the concentration was measured using
the Bradford method. Histone extracts were boiled with sample buffer
for 10 min and separated with 15% SDS PAGE and immunoblotted
with an anti-γ-H2AX antibody (Epitomics).
2.4. Immunoprecipitation
Cells were lysed with immunoprecipitation buffer (50 mMTris–HCl
pH7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 5 mM
EDTA, 1 mM PMSF, 5 μg/ml aprotinin, 5 μg/ml leupeptin, phosphatase
inhibitor 20 mM NaF and 2 mM Na3VO4). For immunoprecipitation,
600~800 μg of protein was mixed with antibodies overnight. The
immune complexes were then incubated with protein bead A or G for
1.5 h. Beads were washed and then mixed with 2× SDS sample buffer
and boiled for 3 min. The samples were loaded on SDS-PAGE and
immunoblotted with speciﬁc antibodies.
2.5. Determination of the CDC25B and SelW redox state
Analysis of the CDC25B redox state was performed as previously
described with slight modiﬁcations [22]. Brieﬂy, NIH3T3 cells were
pretreated with iodoacetamide (IAM) at a ﬁnal concentration of
30 mM for 20 min prior to harvest to irreversibly alkylate free thiols.
Cells were washed twice with cold PBS and lysed with immunopre-
cipitation buffer containing IAM. Excess IAM was removed by passing
lysates though Zeba Spin Desalting Columns (Thermo Scientiﬁc,
Waltham, MA, USA). Lysates were incubated with 3.5 mM DTT at
RT for 30 min to reduce preexisting disulﬁde bonds and passed
through a desalting column to exchange the buffer with a reaction
buffer containing 100 mM Tris–HCl (pH 6.5) and 1 mM EDTA. The ly-
sates were then incubated with 20 μM biotin-conjugated IAM (BIAM)
(Invitrogen) at 37 °C for 30 min in the dark. CDC25B was subsequently
immunoprecipitated, separated by 8% SDS-PAGE and immunoblotted
with HRP-conjugated streptavidin (Invitrogen) to detect BIAM-alkylated
CDC25B. Membranes were stripped with a buffer containing 63 mM
Tris–HCl (pH 6.5) and 2% SDS for 45 min at 55 °C with gentle shaking
and then reprobed with an anti-CDC25B antibody.
2.6. Flow cytometry
For cell cycle analysis, cells were ﬁxed overnight in ice-cold 70% etha-
nol. Cells were collected by centrifugation and resuspended in PBS.
Resuspended cells were treated with RNaseA (50 μg/ml) for 30 min at
RT. Cells were then stained with propidium iodide (50 μg/ml). Subse-
quently, the cell cycle distribution was analyzed using a FACSCalibur
ﬂow cytometer (BD Bioscience, San Jose, CA, USA). To measure the intra-
cellular ROS, cells were incubated with 20 μM 2′, 7′‐dichloroﬂuorescein
diacetate (DCFH-DA) for 15 min and washed twice with cold PBS and
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level of intramolecular ROS was measured using a FACSCalibur ﬂow
cytometer.
2.7. Generation of anti-SelW antibody
A highly antigenic region within the mouse SelW sequence,
N-SKKRGDGYVDTESKF-C, was used for peptide design. Peptide
synthesis and generation of polyclonal antibody against the pep-
tide were provided by Peptron Inc. (Daejeon, Korea).
2.8. Confocal microscopy
Cells on coverslipswerewashedwith cold PBS,ﬁxedwith 3.7% form-
aldehyde for 15 min at RT, permeabilized with 0.1% Triton X-100 for
5 min, and incubated with 2% BSA overnight to block nonspeciﬁc
staining. Cells were then immunostained with anti-CDC25B, phospho-
histone H3, γ-histone H2AX antibodies in 0.1% BSA for 1 h at RT, and
washed 3 times with PBS, and further incubated with ﬂuorescence-
conjugated secondary antibodies (FITC) for 1.5 h at RT. To visualize nu-
clei, cells were stained with DAPI for 3 min. Finally, cells weremounted
onto slides using mounting solution. Immunoﬂuorescence was exam-
ined using a ﬂuorescence microscope (ZEISS LSM 510 META).
2.9. Histone H1 kinase assay
Cells were lysed with buffer containing 20 mM Tris–HCl (pH 7.4),
150 mM NaCl, 1% Triton X-100, 0.5% Sodium deoxycholate, 12 mM
β-glycerophosphate, 10 mM NaF, 5 mM EGTA, 1 mM PMSF, 5 μg/
ml aprotinin and 5 μg/ml leupeptin. And then the lysates were
immunoprecipitated using an anti-Cdk1 or Wee1 antibody over-
night andmixed with protein G beads for 1.5 h. Immune complexes
were washed 3 times with high salt wash buffer containing 300 mM
NaCl, 20 mM Tris–HCl (pH 7.5) and 5 mM EGTA and then 2 times
with low salt wash buffer containing 150 mM NaCl, Tris–HCl (pH 7.5)
and 5 mM EGTA and 1 time with kinase buffer containing 1 mM
Na3VO4, 2 mM DTT, 10 mM MgCl2, 20 mM HEPES (pH 7.4), 12 mM
β-glycerophosphate, 1 mM PMSF, 5 μg/ml aprotinin and 5 μg/ml
leupeptin. Next, immune complexes were resuspended in kinase
buffer plus 1 μl of [γ-32P] ATP and substrate, histone H1 (2 μg) or
GST-Cdk1 proteins (2 μg). Cdk1 immune complexes were incubated at
30 °C for 30 min and Wee1 immune complexes were incubated at
30 °C for 1 h. The reactions were stopped by 2× SDS sample buffer and
boiled at 90 °C for 3 min. Samples were loaded onto 12% SDS-PAGE
gel. The gel was dried at 90 °C for 1 h and exposed to X-ray ﬁlms for
autoradiography.
2.10. CDC25B assay
CDC25B activitywasmeasured based on the activation of Cdk1/cyclin
B1 complexes as previously described with slight modiﬁcations [23].
Brieﬂy, inactive Cdk1/cyclin B1 complexes were immunoprecipitated
from cells treatedwith IR using protein G and an anti-cyclin B1 antibody.
CDC25B proteins were immunoprecipitated with protein G and an
anti-CDC25B antibody from 3 mg cell lysates. CDC25B immune com-
plexeswere incubatedwith Cdk1/cyclin B1 immunoprecipitates in phos-
phatase buffer containing 100 mM Tris–HCl (pH 8.0), 250 mM NaCl,
5 mM EDTA and 10 mM DTT for 15 min at 30 °C. The reaction was
stopped by the addition of kinase assay buffer. To assay the activity of
Cdk1, histoine H1 kinase reactions were performed as described above.
2.11. RNA isolation and RT-PCR
Total cellular RNA was isolated from the cells according to the
manufacturer's instruction using the TRIzol reagent (Invitrogen). 1 μg
RNA was reverse transcribed with oligo (dT) using SuperScriptase™ IIIreverse transcriptase (Invitrogen). PCR was performed using PCR pre-
mix (Rexgene Biotech, Chungcheongbuk-do, Korea) and primers for
detection of SelW as described previously [24]. PCR products were
separated by gel electrophoresis on 2% agarose gel and visualized by
ethidium bromide staining.
2.12. Colony formation, cell viability assay
After NIH3T3 cells were transiently transfected with negative con-
trol or siRNA SelW as described above, 2×103 cells were seeded on
100 mmdishes. 24 h after transfection, cells were treatedwith the indi-
cated dose of IR or etoposide. After 10 days, the dishes were stained
with the MTT reagent. Stained colonies were counted and the degree
of colony formation relative to the control was determined.
In the cell viability assay, transfected MCF7 cells were seeded on
30 mm dishes. 24 h after transfection, cells were treated with the indi-
cated dose of IR. 3 days after treatment, cells were incubatedwith Ez Cy
Tox reagent (Daeil lab Service, Seoul, Korea) for 1.5 h and the absor-
bance was measured using a microplate reader at 460 nm according
to the manufacturer's instructions [25].
3. Results
3.1. SelW is required for mitotic entry after DNA damage
To investigate the role of SelW in the cell cycle, we transiently intro-
duced three different types of siRNA against SelW into NIH3T3 cells
(Table S1). The expression of SelW was efﬁciently reduced by all of
the three siRNAs, and these siRNAs were used in the subsequent exper-
iments. Fig. 1A and supplementary Fig. S1A show the effect of siRNA #2
by real-time PCR and western blot, respectively. The effect of the siRNA
was maintained for 72 h after transfection (Supplementary Fig. S1B).
After transfection, cells were incubated with thymidine for 24 h to
synchronize cells at the G1/S transition (Fig. 1B). After release from
the thymidine block, the cell cycle distribution was then examined by
FACS analysis. As shown in Fig. 1C, the G2–M populations were equal
at 3 h in both control and SelW knockdown cells. However, an increase
in the G2–M population was observed in the SelW knockdown cells
until 9 h after the release from the thymidine block. After this time
point, the G2–M population was identical between the different
cells. To distinguish mitosis from G2, we measured the expression
of phospho-histone H3, a mitotic marker protein. We found that mi-
totic entry of SelW knockdown cells was mildly delayed compared to
that of control cells (Supplementary Fig. S1C), suggesting that SelW
may be involved in the G2–M transition during the cell cycle.
To better understand the role of SelW in the cell cycle, we induced
G2 arrest byγ-irradiation (IR) or etoposide treatment (Fig. 1B). Because
most NIH3T3 cells were synchronized at the G2 phase 3.5 h after
release, the cells were treated with IR (8 Gy) to induce G2 arrest at
this time point. G2 arrest of both control and SelW knockdown cells
was efﬁciently induced by genotoxic stress, indicating that SelW was
not involved in the initiation of cell cycle arrest. However, SelW knock-
down cells showed signiﬁcantly delayed cell cycle recovery fromG2 ar-
restwhen compared to that of the control cells (Fig. 1D, E). The cell cycle
of the control cells recovered from G2 to mitosis or the G1 phase 10 h
after IR; however,most of the SelWknockdown cells remained arrested
at the G2 phase even 20 h after IR. Similar results were obtained with
asynchronous NIH3T3 cells (Supplementary Fig. S1D). These results
suggest that SelW is involved in the G2–M transition and is essential
for cell cycle recovery from G2 arrest induced by DNA damage.
To test whether this delayed recovery was speciﬁc for IR, cells were
also incubated with etoposide for 1 h (Fig. 1B). The recovery from G2
arrest induced by etoposide was also signiﬁcantly retarded in SelW
knockdown cells (Fig. 1F). These results suggest that the effect of
SelW on recovery was not dependent on the type of genotoxic stress
agent. To exclude cell line speciﬁc effects of SelW, cell cycle recovery
Fig. 1. SelW is required for recovery from G2 arrest. NIH3T3 cells were transiently transfected with universal siRNA or SelW siRNA. (A) Cells were harvested 24 h after transfection and
analyzed byWestern blot. (B) The experimental plan described in theMaterials andmethods. (C) After the release of the thymidine block, the DNA contentwas analyzed by FACS analysis
at the indicated time points. Cell cycle proﬁles were obtained with CellQuestPro program (BD Biosciences). The graph shows the results from three independent experiments (n=3,
***pb0.001). (D), (E) The G2–Mpopulation of cells after IR (8 Gy) in (B) was measured and plotted (n=4, **pb0.005, *pb0.05). (F) The G2–Mpopulation of cells treatedwith etoposide
in (B) was determined (n=3, ***pb0.001, **pb0.01). (G) After MCF7 cells were transiently transfected with universal siRNA or SelW siRNA, they were immediately incubated with thy-
midine (2.5 mM) for 26 h. The cells were treated with IR (8 Gy) 5 h after release, and the G2–M population was determined at the indicated time points (n=3, ***pb0.005, **pb0.05).
Error bars in the graph represent±standard deviation (s.d.), and the p value indicates siC versus siSelW.
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cell cycle arrest [26,27]. As shown in Fig. 1G, knockdown of SelW in
MCF7 cells also caused signiﬁcant retardation of recovery from G2
arrest.
To study the molecular mechanism of the recovery defects in SelW
knockdown cells, we measured the activity of the Cdk1/cyclin B1 com-
plex. It is known that Cdk1 is activated by dephosphorylation, and Cdk1
remains inactive until the late G2 phase [28]. As shown in Fig. 2A, Cdk1
remained phosphorylated form in both control and SelW knockdown
cells until 5 h after IR. Subsequently, Cdk1 was dephosphorylated, and
the level of cyclin B1 decreased in control cells. However, cyclin B1
and inactive Cdk1 continuously accumulated until 20 h after IR in
SelWknockdowncells. To conﬁrmmitotic entry after IR,wedetermined
the expression of phospho-histone H3, which was expressed in control
cells 10 h after IR, but not in SelW knockdown cells. The expression of
phospho-histone H3 was further conﬁrmed by immunoﬂuoresence
confocal analysis (Fig. 2B). We also determined the Cdk1 activity
using histone H1 as a substrate. As shown in Fig. 2C, Cdk1 activity was
markedly increased in control cells 8 h after IR. However, there was
no appreciable change in the Cdk1 activity of SelW knockdown cells.
In addition, because it has been reported that the Cdk1/cyclin B1 com-
plex is translocated into the nucleus at the G2–M transition state
[29,30], we compared the level of the Cdk1/cyclin B1 complex in the
nucleus during recovery in both control and SelW knockdown cells.Most of the complexes were present in the cytosol in both cell types
2.5 h after IR. 10 h after IR, the Cdk1/cyclin B1 complexes were
translocated into the nucleus in the control cells but not in the SelW
knockdown cells (Fig. 2D). These results indicate that cells arrested at
G2 could not enter into mitosis without SelW, which might be due to
a failure in activating Cdk1.3.2. SelW regulates the activity of CDC25B
To investigate why the inactivation of Cdk1 was sustained by SelW
knockdown, we analyzed the regulatory pathway of Cdk1 activation.
Phosphorylation of Cdk1 on Tyr 15 is mediated by Wee1 kinase [31],
and the degradation of Wee1 is essential for recovery from G2 arrest
[17]. Abnormal activation of Wee1 resulted in the accumulation of
inhibitory Cdk1. Thus, we measured Wee1 activity using GST-Cdk1 as
a substrate during recovery from G2 arrest. The activity of Wee1 was
not affected by SelW knockdown (Supplementary Fig. S2A). Next, we
examined the level ofWee1 bound to 14-3-3. It is known that the inter-
action between Wee1 and 14-3-3 increased the stability of Wee1 [32].
As shown in Supplementary Fig. S2B, the interaction between the two
proteins was not altered by SelW knockdown. Thus, Wee1 may not be
involved in the sustained inactivation of Cdk1 that was observed in
SelW knockdown cells.
Fig. 2. Delayed recovery caused by sustained inhibition of Cdk1. (A) NIH3T3 cells were
treated with IR as described in Fig. 1A and B and analyzed by Western blot using the
antibodies shown. (B) Phospho-histone H3 was monitored by confocal microscopy
10 h after IR. (C) At the indicated time points, Cdk1 kinase activity was measured
using a histone H1 kinase assay. Input indicates free radiolabled ATP. (D) Cytoplasmic
and nuclear fractions were obtained at the indicated time points after IR (8 Gy) and
immunoblotted using the antibodies shown. Samples were probed for α-tubulin as a
cytoplasmic marker and lamin B1 as a nuclear marker. Scale bar, 20 μm.
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essential for recovery from G2 arrest [17] and that overexpression of
CDC25B caused premature mitosis. In addition, CDC25B was shown to
initially activate the Cdk1/cyclin B1 complex in the cytoplasm during
the prophase [33,34]. Thus, CDC25B is a likely candidate for the
sustained inactivation of Cdk1. Because the activity of CDC25B is tightly
regulated by 14-3-3-mediated cytosolic sequester or substrate binding
inhibition [19,20], we examined the interaction between CDC25B and
Cdk1. Cdk1 was not complexed with CDC25B in both control and
SelW knockdown cells 2.5 h after IR. Their interaction was signiﬁcantlyincreased in control cells at 8 and 10 h after IR, but this increasewas not
observed in SelW knockdown cells (Fig. 3A). To further conﬁrm these
ﬁndings, we measured the CDC25B activity as described in the
Materials and methods. The CDC25B activity increased 8 h after IR in
control cells but not in SelW knockdown cells (Fig. 3B). This result indi-
cates that SelW is important for the reactivation of CDC25B. Because the
activity of CDC25B is regulated by interaction with 14-3-3, we exam-
ined whether downregulation of SelW affected this interaction. Knock-
down of SelW increased the binding of 14-3-3 to CDC25B with or
without DNA damage (Fig. 3C). Because most of the CDC25B is
translocated into the nucleus during recovery after IR [35,36], we ana-
lyzed the distribution of CDC25B using confocal microscopy. CDC25B
mainly existed in the cytosol in both cell types 2.5 h after IR; however,
CDC25B was translocated into the nucleus 10 h after IR in control cells
but not in the SelW knockdown cells (Fig. 3D). These data suggest
that SelW is involved in modulating the activity of CDC25B by control-
ling the interaction between CDC25B and 14-3-3 during the cell cycle.
Because knockdown of SelW increased the binding of 14-3-3 to
CDC25B regardless of irradiation, we investigated whether SelW affect-
ed the activity of ectopic CDC25B bymeasuring the level of phosphory-
lation of Cdk1 at Tyr 15, which is removed efﬁciently by ectopic
expression of CDC25B [34]. As expected, phospho-Cdk1was signiﬁcant-
ly decreased in cells overexpressing CDC25B under normal conditions.
However, the dephosphorylation activity of ectopic CDC25B was
suppressed by SelW knockdown (Fig. 3E). These data indicate that the
inactive CDC25B was responsible for the sustained phosphorylation of
Cdk1 at Tyr 15, which resulted in delayed recovery from G2 arrest in
SelW downregulated cells.
3.3. Delayed recovery is not due to the antioxidant activity of SelW, DNA
repair rate or abnormal activation of checkpoint kinases
Althoughwe found that SelWwas involved in regulating the dissoci-
ation of 14-3-3 from CDC25B, we could not exclude another possible
cause for the delayed recovery from G2 arrest. IR and etoposide, which
were used to induce DNA damage in this study, generate reactive
oxygen species (ROS) in cells [37], and SelW might possess antioxidant
activity [6,7]. Thus, we investigated whether knockdown of SelW
increased intracellular ROS after DNA damage. There was no signiﬁcant
difference in the ROS level in both control and SelW knockdown cells
(data not shown). This result was consistent with a previous report,
which found that the antioxidant function of SelWmight be compensat-
ed by other intracellular antioxidant proteins [38]. Next, we pretreated
the cells with N-acetyl cysteine (NAC) before IR and then analyzed the
recovery from G2 arrest in SelW knockdown cells. The level of intracel-
lular ROSwasmaintained constant by NAC pretreatment until 10 h after
IR in both cell types (Fig. 4A). However, the recovery of SelW knock-
down cells was still delayed (Fig. 4B), which indicated that the antioxi-
dant function of SelW did not affect the recovery from G2 arrest. Next,
we determined the level of phospho-histone H2AX (designated as
γ-histone H2AX). As DNA damaging reagents induce phosphorylation
of histone H2AX at Ser 139, γ-histone H2AX was used as a marker of
DNA damage [39]. As shown in Fig. 4C, reduction of SelW expression
did not affect the phosphorylation of histone H2AX at 0 h, indicating
that knockdown of SelW did not cause DNA damage without IR. In addi-
tion, if SelW affects the repair rate of double strand breaks, the rate of
γ-histone H2AX foci loss would differ between the control and SelW
knockdown cells. Thus, we measured the rate of γ-histone H2AX foci
loss by immunoﬂuorescence using a γ-histone H2AX antibody. The
average foci of γ-histone H2AX after IR were not different between the
two cell types, indicating that SelW did not affect the DNA repair rate.
Consistent with the confocal analysis, a loss of γ-histone H2AX was also
observed in the immunoblotting assay (Supplementary Fig. S3). Next, to
determine whether the delayed recovery from G2 arrest was mediated
by upstream kinases, we measured the phosphorylation of ATM and
Chk1, which are responsible for the inactivation of CDC25B after DNA
Fig. 3. CDC25B is responsible for the accumulation of inactive Cdk1. (A) Cell lysates in Fig. 2A were immunoprecipitated with an anti-CDC25B antibody and then immunoblotted with an
anti-Cdk1 antibody. (B) The phosphatase assay and kinase assay were performed as described in the Materials and methods using immunoprecipitates in (A). (C) NIH3T3 cells were
cotransfected with universal siRNA or SelW siRNA, HA-14-3-3β and CDC25B-ﬂag. Cells were either untreated or treated with IR (8 Gy) 24 h after transfection. Cells were harvested
5 h after IR and immunoprecipitated with an anti-HA antibody. Samples were immunoblotted with an anti-ﬂag antibody. (D) Cells in Fig. 2A, but plated on a coverslip, were ﬁxed and
stained for CDC25B (green) and DAPI (blue) at the indicated time points after IR. Images of the samples were obtained using a confocal microscope. (E) NIH3T3 cells with and without
cotransfection with universal siRNA or SelW siRNA and a CDC25B-ﬂag vector. The cells were harvested 24 h after transfection and analyzed by Western blot using the antibodies
shown. Scale bar, 20 μm.
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entry. Abnormal activation of these kinases can inactivate CDC25B. Phos-
phorylation of ATM and Chk1 was very low in both cell types without IR.
They were signiﬁcantly increased 2.5 h after IR and then gradually
returned to basal levels in both cell types (Fig. 4D), indicating that SelW
did not affect the activities of DNA checkpoint kinases.
3.4. SelWmodulates reactivation of CDC25B by the reduction of the intramo-
lecular disulﬁde bond in CDC25B
To conﬁrm that SelW is involved in the activation of CDC25B, we
investigated whether SelW interacted with CDC25B. We found that
SelW can interact with CDC25B and that interaction of SelW with
CDC25B increased after DNA damage and decreased during recovery,
which was similar to the normal mitosis phase (Fig. 5A, upper panel).
We also found that the interaction was signiﬁcantly increased after DNA
damage using tagged proteins (Fig. 5A, lower panel). Identiﬁcation of
SelW as a positive regulator of CDC25B raised the question of whether
this regulation was mediated by 14-3-3 proteins. CDC25C is regulated
through a redox-dependent mechanism [21], and most phosphatases
are regulated by the cellular redox state [40,41]. In addition, CDC25 phos-
phatases contain a highly reactive Cys in the active site and a backdoor
Cys, which forms a disulﬁde bond with the active site Cys that inactivate
CDC25 phosphatases [18]. For CDC25C, an intramolecular disulﬁde bond
is required for binding to 14-3-3 [21]. Among the various redox regulated
phosphatases, PTEN (phosphatase and tensin homolog) is well known to
form intramolecular disulﬁde bonds, which is regulated by Trx [42].Because CDC25B is a redox regulated phosphatase and SelW contains a
CXXU motif like Trx, we hypothesized that SelW may release 14-3-3
from CDC25B by reducing the intramolecular disulﬁde bond. To test this
hypothesis, we measured the level of 14-3-3 bound to CDC25B after
DNA damage. Consistent with Fig. 3C, the binding of 14-3-3 to CDC25B
10 h after IRwas slightly decreased compared to the level at 2.5 h in con-
trol cells; however, the binding was signiﬁcantly increased in SelW
knockdown cells (Fig 5B). Because binding of 14-3-3 to CDC25B may be
controlled in a redox-dependent manner, as was observed for CDC25C,
we analyzed the formation of an intramolecular disulﬁde bond in
CDC25B in both cell types. To do this, we measured the redox state of
endogenous CDC25B using a two-step alkylation assay as described
in the Materials and methods. Compared to control cells, oxidized
CDC25B containing an intramolecular disulﬁde bond was signiﬁcantly
accumulated in SelW knockdown cells 10 h after IR (Fig. 5C). Because
SelW regulated the redox state of CDC25B, we investigated whether
ectopic expression of SelWmodulated recovery from G2 arrest. Although
SelW cDNA was constructed with the SECIS element (selenocysteine
insertion sequence), ectopic expression of wild type SelWwas very difﬁ-
cult toworkwith because the codon for Sec, UGA,was often recognized as
a stop codon. Thus, we used amutant SelW inwhich the Secwas replaced
with a Cys (U13C). Although the U13C mutant was overexpressed in
NIH3T3 cells, the G2–M population of cells overexpressing U13C was
not different from that of control cells (Fig. 5D). This result indicates
that the U13C mutant may not reduce oxidized CDC25B or that the
U13Cmutantwas not involved in the recovery processwhen endogenous
SelW exists in cells. To determine between these two possibilities, we
Fig. 4. Delayed recovery is not related to antioxidant activity, DNA repair rate or activation of upstream kinases. (A) Cells in Fig. 2A, but subsequently pretreated with NAC (5 mM) after
thymidine block release. Relative ROS levels compared to the control weremeasured at the indicated time point (n=3, ***pb0.0001; control versusNAC). The control is indicated at 0 h of
siC without NAC treatment. (B) The G2–M population of cells in (A) was measured (n=3, ***pb0.001; siC versus siSelW). (C) Cells in Fig. 3D were ﬁxed at the indicated time point and
stained with an anti-γ-histone H2AX antibody. Images of the samples were obtained using confocal microscopy. The number of foci per nucleus was counted using the ImageJ program
(NIH). At least 20 cellswere counted for each time point. (D) Cells in Fig. 2Awere harvested at the indicated time and immunoblottedwith the indicated antibodies. Error bars in the graph
represent±s.d. Scale bar, 5 μm.
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tantwas able to resume the cell cycle after IR in endogenous SelWknock-
down cells. Tomeasure this ability, we knocked down SelW inMCF7 cells
and then ectopically expressed the mouse U13C mutant, which is resis-
tant to human SelW siRNA. Using these cells, we found that the U13C
mutant did not decrease the level of phospho-Cdk1 and could not reduce
intramolecular disulﬁde bonds in CDC25B (Fig. 5E). Thus, these results
clearly demonstrated that the U in the CXXU motif of SelW is essential
for reducing disulﬁde bonds, which is consistent with previous data[43,44]. To test if the knockdown of SelW only affected the redox state
of CDC25B during recovery, cells were incubated with dithiothreitol
(DTT). When CDC25B was reduced by DTT, the accumulation of
the 14-3-3/CDC25B complex caused by SelW knockdown decreased
(Fig. 5F). To further conﬁrm these ﬁndings, we treated the cells with
diamide, a thiol-oxidizing reagent, to sustain the oxidized state of
CDC25B. As NIH3T3 cells entered into mitosis 10 h after IR, the level of
14-3-3 bound to CDC25B was hardly detected; however, the 14-3-3/
CDC25B complex still remained in diamide-treated cells (Fig 5G). These
Fig. 5. SelW regulates the dissociation of 14-3-3 from CDC25B by reducing the intramolecular disulﬁde bond in CDC25B. (A) Cells in Fig. 2A were immunoprecipitated with an
anti-CDC25B antibody and immunoblotted with an anti-SelW antibody at the indicated time. M indicates 6 h after thymidine block release (upper panel). NIH3T3 cells were
transfected with His-SelW (U13C) and CDC25B-ﬂag. Cells were either untreated or treated with IR (8 Gy) 24 h after transfection. Cells were immunoprecipitated with an
anti-His antibody 5 h after IR and immunoblotted with an anti-ﬂag antibody. (B) Cells in Fig. 2A were immunoprecipitated with an anti-CDC25B antibody and then
immunoblotted with an anti-14-3-3 antibody. (C) Cells in (B) were pretreated with IAM (30 mM) for 20 min prior to harvest. The cells were harvested 10 h after IR, and the
intramolecular disulﬁde bonds of CDC25B were measured as described in the Materials and methods. (D) NIH3T3 cells were transfected with empty vector or SelW (U13C)
and treated with IR as described in Fig. 1B. The G2–M population of the cells was measured. (E) MCF7 cells were cotransfected with universal siRNA or human SelW siRNA
and empty vector or His-SelW (U13C) and treated as described in the Materials and methods. The cells were immunoblotted with the antibodies shown or cells were incubated
with IAM (30 mM) for 20 min prior to harvest 12 h after IR and then analyzed as described in (C). (F) NIH3T3 cells were cotransfected with universal siRNA or SelW siRNA in
addition to HA-14-3-3β and CDC25B-ﬂag and subsequently incubated with thymidine for 24 h. Cells were treated with IR (8 Gy) 3.5 h after release. Cells were incubated with or
without DTT (5 mM) for 1 h prior to harvest. Cells were immunoprecipitated with an anti-HA antibody 12 h after IR and immunoblotted with an anti-ﬂag antibody. (G) Cells
in (F) were incubated with or without diamide (100 μM) for 2 h prior to harvest and incubated with or without DTT (5 mM) for 1 h prior to harvest. The cells were
immunoprecipitated 10 h after IR as described in (F). Error bars in the graph represent±s.d.
2224 Y.H. Park et al. / Biochimica et Biophysica Acta 1823 (2012) 2217–2226results indicate that the redox-dependent inactivation of CDC25B
involves reversible Cys oxidation, which is reduced by SelW.
3.5. SelW knockdown increases sensitivity to anticancer drugs
Because SelW was necessary to activate CDC25B by reducing intra-
molecular disulﬁde bonds during recovery from G2 arrest as described
above, we performed an experiment to determine if downregulation of
SelW affected cell sensitivity to DNA damaging agents. Compared to thecontrol cells, SelW knockdown cells were more sensitive to both DNA
damaging agents (Fig. 6A, B). It is known that Trx is overexpressed and
highly associated with PTEN in various tumor cells [45]. Trx has been
proposed as a therapeutic target for cancer therapy based on the ﬁndings
that reduction in the level of Trx decreased tumor progression and me-
tastasis in mice [46]. In addition, CDC25B overexpression has been
reported in many human cancers, and it is considered a target for anti-
cancer drugs [47,48]. As we have shown here that SelW functions to
activate CDC25B during the cell cycle, we tested whether depletion of
Fig. 6. SelWknockdown increases sensitivity to anticancer drugs. (A), (B) For the colony formation assay, NIH3T3 cells were treated as described inMaterials andmethods. 2×103 cells were
plated and cultured for 10 days after transfection before staining with MTT, and the number of colonies was counted based on colony size. The bar graph shows the number of colonies
relative to untreated cells for three independent experiments. Error bars in the graph represent±s.d. (n=3, ***pb0.001; **pb0.01; siC versus siSelW).
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downregulated MCF7 cells showed decreased viability after treatment
with the DNA damaging agents IR (Supplementary Fig. S4A) and
etoposide (data not shown), and similar results were obtained with
another cancer cell line, A549 (Supplementary Fig. S4B). Taken together,
these results indicate that SelW knockdown causes delayed CDC25B
activation after DNA damage, which reduces cell viability.
4. Discussion
4.1. Regulation of CDC25B activity by SelW
SelW is a selenoprotein that contains a redox active CXXU motif,
indicating that itmayhave redox-dependent regulatory function.Wepre-
viously reported that SelWprotects cells fromoxidative stress [6,7]. How-
ever, it was also recently reported that this antioxidant activity might not
be the main function of SelW [38]. Furthermore, it has been shown that
SelW interacts with 14-3-3 proteins [8–10]. The data presented here
demonstrate that SelW is dispensable for the normal cell cycle, although
the cell cycle was slightly delayed, but it was essential for mitotic entry
following recovery fromG2 arrest (Fig. 1C, E). These observations indicate
that SelW regulates proteins that are involved in the G2–Mtransition and
is essential for recovery from G2 arrest. In addition, we found that SelW
knockdown delayed the recovery from G2 arrest and the accumulation
of inactive Cdk1 when compared to control cells (Fig. 2A). Because inac-
tive Cdk1 might be correlated with a sustained activation of checkpoint
kinases,wemeasured thephosphorylation of checkpoint kinases.Howev-
er, the activity of checkpoint kinases was not signiﬁcantly affected by
SelWknockdown (Fig. 4D). In addition, knockdown of SelWdid not affect
cellular ROS levels and DNA repair rates (data not shown, Fig. 4C). Thus,
we focused on identifying the driver of mitotic reentry, the CDC25 phos-
phatases, which remove the inhibitory phosphate from Cdk1. Because
only CDC25B, among the various isoforms of CDC25, is the essential acti-
vator of Cdk1 during recovery after genotoxic stress [17], we investigated
the activity of CDC25B. Because the role of CDC25Bwas shown to be com-
pensated by CDC25A or C in the normal cell cycle [33], SelW knockdown
did not affect the normal cell cycle signiﬁcantly, although SelW knock-
down enhanced the binding of 14-3-3 to CDC25B with or without DNA
damage. Because the activity and localization of CDC25B are regulated
by 14-3-3 [19,20] and SelW interacts with 14-3-3, we investigated
whether SelW controlled the activity of CDC25B by regulating thedissociation of 14-3-3 from CDC25B. As shown in Fig. 3D and E, CDC25B
in SelW-downregulated cells was inactivated and localized mainly in
the cytosol. Thus, CDC25B existed in a sustained inactive form due to con-
tinuous interaction with 14-3-3. These results indicate that SelW regu-
lates the activity of CDC25B by releasing 14-3-3 from CDC25B, although
we could not determine the mitotic reentry by overexpression of wild
type SelW in SelW knockdown cells. Recently, it has been suggested
that SelW knockdown caused G1 arrest by increasing level of MKK4
[49]. And, we observed t that proliferation was reduced in SelW knock-
down MCF7 cells. Therefore, SelW may regulate cell cycle in various
mechanisms.
4.2. A model for CDC25B reactivation by SelW
CDC25 phosphatases belong to the dual-speciﬁcity phosphatase fam-
ily containing Cys in the active site. Because the pKa of Cys in the active
site of CDC25B is unusually low (5.6–6.3), its oxidized form is not
reduced by GSH [50]. Thus, when we pretreated with NAC, inactive
CDC25B was not activated, and the effect of SelW knockdown might be
maintained. It is known that the association of 14-3-3 with CDC25C
requires disulﬁde formation between two reactive Cys residues within
CDC25C [21]. We found that SelW regulated the dissociation of 14-3-3
from CDC25B (Figs. 3C, 5B). Because of the conserved CXXU motif,
we supposed that SelWmight activate CDC25B by reducing the intramo-
lecular disulﬁde bond, which would result in the dissociation of bound
14-3-3 from CDC25B during recovery. Although we were not able to dis-
tinguish between the reduced and oxidized form of CDC25B due to the
various spliced forms of CDC25B [51],we performed a quantitative exper-
iment using BIAM labeling to measure the oxidation status of CDC25B.
From this experiment, we found that signiﬁcantly higher amounts of
the oxidized form had accumulated in SelW knockdown cells (Fig. 5C).
Taken together, we suggest that the reduction of CDC25B mediated by
SelW is required for initiating the cell cycle after DNA damage.
4.3. SelW as a potential target for cancer therapy
Many studies have found increased CDC25B expression in a wide
variety of cancers [47,48]. It has been reported that misregulation of
CDC25 contributes to genomic instability, and CDC25B is overexpressed
in breast cancers [52]. Because SelW was able to convert oxidized
CDC25B to a reduced form, this protein may contribute to the
2226 Y.H. Park et al. / Biochimica et Biophysica Acta 1823 (2012) 2217–2226tumorigenesis pathway. We found that SelW knockdown in MCF7 cells
showed increased sensitivity to anticancer drugs than control cells
(Supplementary Fig. S4A). Because the compounds currently used for
CDC25 inhibition aremore effectivewhen associatedwith an anticancer
drug, knockdown of SelW may enhance the effect of anticancer drugs.
Consistent with these suggestions, our studies have shown that SelW
knockdown intensiﬁed the cytotoxicity of DNA damaging agents, such
as IR or etoposide (Fig. 6A, B). In addition, based on the novel function
of SelW, which governs binding of a substrate to CDC25B in vivo, SelW
may be a valid target for the design of drugs that reduce tumor growth
and enhance the efﬁcacy of chemotherapeutic drugs in cancers that
overexpress CDC25B. In conclusion, we suggest that SelW is involved in
the recovery from G2 arrest through the activation of CDC25B, which is
mediated via reducing intramolecular disulﬁde bonds.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.09.001.
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